StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Get Rating) in a research report released on Friday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of NYSE:CO opened at $2.99 on Friday. The stock has a market capitalization of $363.14 million, a PE ratio of 4.67 and a beta of -0.04. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The firm has a fifty day moving average price of $2.92 and a 200 day moving average price of $2.73.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. National Asset Management Inc. acquired a new position in Global Cord Blood during the 1st quarter worth $39,000. Campbell & CO Investment Adviser LLC acquired a new position in shares of Global Cord Blood during the first quarter valued at about $56,000. Northern Trust Corp acquired a new position in shares of Global Cord Blood during the second quarter valued at about $96,000. Benjamin F. Edwards & Company Inc. acquired a new position in shares of Global Cord Blood during the third quarter valued at about $176,000. Finally, Natixis Advisors L.P. raised its position in shares of Global Cord Blood by 5.6% during the second quarter. Natixis Advisors L.P. now owns 199,880 shares of the medical research company’s stock valued at $592,000 after buying an additional 10,550 shares during the last quarter.
Global Cord Blood Company Profile
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.
- Get a free copy of the StockNews.com research report on Global Cord Blood (CO)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Microsoft Shares: Is it Time to Back Up the Truck?
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.